ArticleJournal of experimental & clinical cancer research : CR2024

MDM2 drives resistance to Osimertinib by contextually disrupting FBW7-mediated destruction of MCL-1 protein in EGFR mutant NSCLC.

Jiaxin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.